Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome
SF Heeringa, CN Vlangos, G Chernin… - Nephrology Dialysis …, 2008 - academic.oup.com
Nephrology Dialysis Transplantation, 2008•academic.oup.com
Background. Congenital nephrotic syndrome (CNS) is de-fined as nephrotic syndrome that
manifests at birth or within the first 3 months of life. Most patients develop end-stage renal
disease (ESRD) within 2 to 3 years of life. CNS of the Finnish-type (CNF) features a rather
specific renal histology and is caused by recessive mutations in the NPHS1 gene encoding
nephrin, a major structural protein of the glomerular slit-diaphragm. So far, more than 80
different mutations of NPHS1 causing CNF have been published. Methods. Here, we …
manifests at birth or within the first 3 months of life. Most patients develop end-stage renal
disease (ESRD) within 2 to 3 years of life. CNS of the Finnish-type (CNF) features a rather
specific renal histology and is caused by recessive mutations in the NPHS1 gene encoding
nephrin, a major structural protein of the glomerular slit-diaphragm. So far, more than 80
different mutations of NPHS1 causing CNF have been published. Methods. Here, we …
Abstract
Background. Congenital nephrotic syndrome (CNS) is de- fined as nephrotic syndrome that manifests at birth or within the first 3 months of life. Most patients develop end-stage renal disease (ESRD) within 2 to 3 years of life. CNS of the Finnish-type (CNF) features a rather specific renal histology and is caused by recessive mutations in the NPHS1 gene encoding nephrin, a major structural protein of the glomerular slit-diaphragm. So far, more than 80 different mutations of NPHS1 causing CNF have been published.
Methods. Here, we performed mutation analysis of NPHS1 by exon sequencing in a worldwide cohort of 32 children with CNS from 29 different families.
Results. Sixteen of the 29 families (55%) were found to have two disease-causing alleles in NPHS1. Two additional patients had a single heterozygous mutation in NPHS1. Thirteen of a total of 20 different mutations detected were novel (65%). These were five missense mutations, one nonsense mutation, three deletions, one insertion and three splice-site mutations.
Conclusion. Our data expand the spectrum of known NPHS1 mutations by >15% in a worldwide cohort. Surprisingly, two patients with disease-causing mutations showed a relatively mild phenotype, as one patient had a partial remission with steroid treatment and one patient had normal renal function 1 year after the onset of disease. The increased number of known mutations will facilitate future studies into genotype/phenotype correlations.
Oxford University Press